We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Planning Disease-Specific Guidances and Endpoints for New Gene Therapies
FDA Planning Disease-Specific Guidances and Endpoints for New Gene Therapies
The FDA is planning to deliver a suite of disease-specific guidance documents next year on developing targeted gene therapies, starting with hemophilia and then more common single-gene disorders, Commissioner Scott Gottlieb told senators Thursday.